OptimumBank Holdings, Inc. Announces Formation of OptimumFunding to Launch HUD and FHA Lending Platform
Globenewswire· 2026-02-23 13:30
FORT LAUDERDALE, Fla., Feb. 23, 2026 (GLOBE NEWSWIRE) -- OptimumBank Holdings, Inc. (NYSE American: OPHC) (“Company”) announced today the formation of OptimumFunding, LLC (“OptimumFunding”), a wholly owned subsidiary created to support a new HUD and FHA lending initiative, representing a significant milestone in the Company’s long-term strategic growth plan. OptimumFunding has been established to expand the Company’s commercial real estate lending capabilities by offering bridge-to-HUD financing, as well as ...
Plexus to Present at the Raymond James 47th Annual Institutional Investors Conference
Globenewswire· 2026-02-23 13:30
NEENAH, WI, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) announced today that it will attend the Raymond James 47th Annual Institutional Investors Conference in Orlando, FL on March 2, 2026. During the conference, Raymond James will host a fireside chat with Plexus’ management team at 10:25 a.m. Eastern Time. The fireside chat will be available via live webcast. What:Plexus Fireside Chat and Webcast at the Raymond James 47th Annual Institutional Investors Conference When:Monday March 2, 20 ...
Trident Resources Accelerates Winter Exploration Program with the Addition of a Third Drill Rig to the Contact Lake Gold Project in Northern Saskatchewan, Canada
Globenewswire· 2026-02-23 13:30
Vancouver, BC, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Trident Resources Corp. (TSXV: ROCK) (OTCQB: TRDTF) (“Trident” or the “Company”) is pleased to announce that its Winter 2026 drilling program is being accelerated with the mobilization of a third drill rig. The Company is well funded and is highly encouraged with the visual indications of mineralization thus far in the winter program and has decided to add an additional rig to expedite and expand on the initial drilling plan. Trident intends to continue drill ...
Adial Pharmaceuticals Highlights FDA Policy Direction That May Reduce Pivotal Trial Burden from Two Studies to One
Globenewswire· 2026-02-23 13:30
Core Insights - The FDA's recent policy shift allows for drug approval based on one adequate and well-controlled clinical investigation plus confirmatory evidence, rather than the traditional requirement of two pivotal studies, which could significantly lower costs and accelerate the NDA submission process for Adial's lead drug candidate, AD04 [1][2][3] Company Overview - Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing therapies for addiction and related disorders, with its lead investigational drug candidate, AD04, targeting Alcohol Use Disorder (AUD) in heavy drinking patients [5] - AD04 is a genetically targeted serotonin-3 receptor antagonist, and the company is preparing for a new Phase 3 clinical trial program, utilizing a proprietary diagnostic genetic test to identify target genotypes [5] Regulatory Impact - The FDA's modernization of evidentiary standards emphasizes trial quality and confirmatory support over the number of trials, which aligns with Adial's strategy to potentially conduct a single pivotal trial for AD04 [2][4] - Cary Claiborne, CEO of Adial, highlighted that this regulatory change could transform the company's development strategy by significantly lowering Phase 3 costs and improving capital efficiency [4] Clinical Development Strategy - Adial intends to engage closely with the FDA to align its evidentiary strategy for AD04 with current regulatory standards, which may enhance the strategic and economic profile of the asset [4][7] - The company believes that AD04 has the potential to treat other addictive disorders beyond AUD, including Opioid Use Disorder, gambling, and obesity [5]
Ultragenyx Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application (BLA) for DTX401 AAV Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa)
Globenewswire· 2026-02-23 13:30
PDUFA action date set for August 23, 2026 If approved, DTX401 will be the first treatment to address the underlying cause of GDSIa NOVATO, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced the U.S. Food and Drug Administration (FDA or the Agency) has accepted for review the Biologics License Application (BLA) seeking approval of DTX401 AAV gene therapy (pariglasgene brecaparvovec) for the treatment of Glycogen Storage Disease Type Ia (GSDIa). The FDA gra ...
Off The Hook to Host Investor Webinar to Discuss APEX Acquisition Expected to Add $30M in Revenue and Deliver $3M in Annual Cost Savings
Globenewswire· 2026-02-23 13:30
Wilmington, NC, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Off The Hook YS Inc. (NYSE American: OTH) (“Off the Hook Yachts” or “Off the Hook” or “the Company”), a vertically integrated, AI-powered marine marketplace and the largest buyer and seller of used boats in the nation, is pleased to invite investors to a webinar on February 23, 2026, at 4:15 p.m. ET. The exclusive event, hosted by RedChip Companies, will feature Brian John, CEO of Off The Hook Yachts, who will discuss the Company’s recently announced definit ...
American Rebel Holdings, Inc. (NASDAQ: AREB) announces a partnership with Jefferson Distributing to launch American Rebel Light Beer in West Virginia’s Eastern Panhandle, expanding distribution across Jefferson, Morgan and Berkeley Counties
Globenewswire· 2026-02-23 13:30
American Rebel Holdings, Inc. American Rebel Holdings, Inc. (NASDAQ: AREB) announces a partnership with Jefferson Distributing to launch American Rebel Light Beer in West Virginia’s Eastern Panhandle Top-tier Anheuser-Busch network distribution partner Jefferson Distributing (WV) adds critical “footprint fill-in” coverage as American Rebel continues rapid national expansion with sustained execution of its Distribution-First strategy Nashville, TN, Feb. 23, 2026 (GLOBE NEWSWIRE) -- American Rebel Holding ...
ARKO Corp. Opens Newly Remodeled Apple Market with fas craves Food Concept in Hazard, KY
Globenewswire· 2026-02-23 13:30
Core Insights - ARKO Corp. has opened a newly remodeled Apple Market featuring the fas craves food concept, marking the fourth fas craves remodel and bringing the total to six locations nationwide [6][10] Group 1: Store Opening and Concept - The remodeled Apple Market store opened on February 16, 2026, with a grand opening celebration planned for early spring [7] - The fas craves concept aims to redefine the convenience store experience with high-quality, delicious, and affordable menu items [8] - The store features an updated exterior and interior, including modern digital menu boards and enhanced layout for improved guest flow [10] Group 2: Menu Offerings - The elevated menu includes Hot and Cold Grab-n-Go items, Roller Grill favorites, and a variety of popular food items such as breakfast sandwiches and chicken wings [8] - The beverage lineup includes trending options like dirty soda, nitro cold brew, and various iced drinks [9] Group 3: Customer Engagement and Loyalty - ARKO's fas REWARDS® loyalty program offers savings on everyday purchases, including stackable fuel rewards up to $2.50 per gallon [11][12] - The program enhances customer experience by providing personalized offers and better in-store pricing [12] Group 4: Company Overview - ARKO Corp. is a Fortune 500 company and one of the largest convenience store operators in the U.S., operating in four segments: retail, wholesale, fleet fueling, and GPM Petroleum [13][16]
rYojbaba Announces Participation in the Guardian Girls Aikido Project in Los Angeles, CA
Globenewswire· 2026-02-23 13:30
FUKUOKA, Japan, Feb. 23, 2026 (GLOBE NEWSWIRE) -- rYojbaba Co., Ltd. (Nasdaq: RYOJ) ("rYojbaba" or the "Company"), a Japanese consulting and health services company, collaborated with Guardian Girls USA and United Nations Population Fund (“UNFPA”) to launch the Guardian Girls Aikido (“GGA”) project at the Terasaki Budokan in downtown Los Angeles, California. The Guardian Girls Aikido project was originally launched in Bogotá, Colombia, in February 2024, in cooperation with the Embassy of Japan in Colombia. ...
IP Strategy Launches Treasury Yield-Enhancement Program
Globenewswire· 2026-02-23 13:30
New program off to a successful start with 3.96% average monthly yield after first four weeksGIG HARBOR, Wash., Feb. 23, 2026 (GLOBE NEWSWIRE) -- IP Strategy Holdings, Inc. (Nasdaq: IPST) (the “Company” or “IP Strategy”), the first company to adopt a treasury reserve policy centered on the $IP token, today announced the launch of a new treasury yield-enhancement program earning an average monthly yield of 3.96%% (or 59.37% on a compounded annualized basis). In its first four weeks of testing, the program ge ...